-transparent.png){kind=logo}
The blood level achieved with 15 mg/kg ordinary isoniazid (INH) was compared with that obtained with INH slow releasing Matrix preparation. Three brands of INH Matrix preparation were compared namely: the product of ICN Canada Ltd, utilized by Laboratory Centre for Disease Control, the preparation of Smith and Nephew, Britain employed by the Tuberculosis unit of the British Medical Research Council and Tebesium, the product of Hefa-Frenon Arzneimittel, Germany studied by the Tuberculosis Unit of South African Medical Research Council. The results of this study showed that pharmacogenetic principle have to be taken into account, it is not possible to produce INH slow releasing Matrix preparate equally applicable for slow and fast acetylators of INH.
M M Hodgkin, and
L Eidus, and
E S Hershfield
February 1972,
Lancet (London, England),
M M Hodgkin, and
L Eidus, and
E S Hershfield
January 1975,
Problemy tuberkuleza,
M M Hodgkin, and
L Eidus, and
E S Hershfield
January 1973,
The Indian journal of chest diseases,
M M Hodgkin, and
L Eidus, and
E S Hershfield
October 1970,
British medical journal,
M M Hodgkin, and
L Eidus, and
E S Hershfield
October 1977,
The Indian journal of chest diseases & allied sciences,
M M Hodgkin, and
L Eidus, and
E S Hershfield
March 1974,
Tubercle,
M M Hodgkin, and
L Eidus, and
E S Hershfield
February 1998,
Archives of disease in childhood,
M M Hodgkin, and
L Eidus, and
E S Hershfield
February 1977,
British journal of clinical pharmacology,
M M Hodgkin, and
L Eidus, and
E S Hershfield
September 1974,
The American review of respiratory disease,
M M Hodgkin, and
L Eidus, and
E S Hershfield
November 1958,
Revista brasileira de tuberculose e doencas toracicas,
